IOR (BSE:IORB) 3-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:IORB IOR SA BSE:IORB
25 GF Score
Price lei0.21
View Full Analysis

What is IOR 3-Year EBITDA Growth Rate?

IOR BSE:IORB 25 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates BSE:IORB with a GF Score™ of 25/100. Among 688 Medical Devices & Instruments companies, IOR ranks worse than 145348.69% on this metric.

IOR's EBITDA per Share for the three months ended in Jun. 2026 was lei0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

IOR  (BSE:IORB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

IOR 3-Year EBITDA Growth Rate Related Terms

BSE:IORB vs SECI, LENSF, ASNB: 3-Year EBITDA Growth Rate Comparison

For the Medical Instruments & Supplies subindustry, IOR's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IOR 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IOR's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where IOR's 3-Year EBITDA Growth Rate falls into.


BSE:IORB
25GF Score
IOR SA BSE:IORB
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOR 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
IOR (BSE:IORB) has a 3-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for IOR and its competitors. According to the industry distribution chart, IOR ranks #999999 out of 688 companies in the Medical Devices & Instruments industry.
Is IOR's 3-Year EBITDA Growth Rate too high?
IOR's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, IOR ranks #999999 out of 688 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, IOR has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does IOR's 3-Year EBITDA Growth Rate compare to SECI and LENSF?
According to the Medical Devices & Instruments industry distribution chart, IOR ranks #999999 out of 688 companies for 3-Year EBITDA Growth Rate. This places IOR in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.10, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for IOR and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOR's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOR stock overvalued right now?
IOR (BSE:IORB) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. IOR's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For IOR (BSE:IORB), the current 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IOR Business Description

Address Bucovina Street No. 4, Sector 3, Bucharest, ROU, 030393
IOR SA is a Romanian manufacturer of optical and opto-mechanical products based in Bucharest. The company designs and produces a range of optics, including sport optics such as binoculars and riflescopes, military and defense optics, medical optical equipment, eyewear lenses, and loose optical components. It also performs precision opto-mechanical processing and custom optical glass fabrication. Its customers span civilian consumers, healthcare providers, military and law enforcement buyers, and industrial clients requiring specialized optical components. Revenue is generated primarily through the sale of manufactured optical products and related opto-mechanical apparatus, with additional income from custom design and processing services. The company serves the Romanian market and exports to international customers.
25GF Score

Get the complete analysis for BSE:IORB

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.21
Price